Fibrodysplasia Ossificans Progressiva (FOP) remains one of the most misunderstood and misdiagnosed rare diseases. Because the condition is extremely rare, many healthcare professionals and community members confuse it with more common illnesses. Some mistake FOP for arthritis because of the joint stiffness and pain during flare-ups. Others assume it develops after trauma or infection and […]
FOP research is advancing steadily, bringing hope to patients and families worldwide. In 2025, one of the biggest developments is the Phase 2 trial of the STOP-FOP study, which focuses on the drug saracatinib. Originally developed for other conditions, saracatinib has shown promise in reducing flare-ups and slowing abnormal bone growth in FOP. Another promising […]
The International FOP Association (IFOPA) was founded in 1988 by Jeannie Peeper, one of the first individuals diagnosed with Fibrodysplasia Ossificans Progressiva (FOP). From a small patient-led initiative, IFOPA has evolved into a global organization that champions FOP awareness, supports groundbreaking research, and empowers patients and families around the world. FOP is one of the […]
Day One: Compassion in Action (June 9, 2025) The week began with patient check-ins. Ms. Asha Shetty was healing from jaw pain after using a gel prescribed by Dr. Rajesh. Samed Ali had recovered from a fever. Lashmamma, who completed a course of antibiotics, reported less gum pain. Meanwhile, Pranav, a recent surgery patient, was […]
A Brave Heart from Chengannur In the quiet town of Chengannur in Kerala’s Alappuzha District lives 10-year-old Devanda. She shows incredible courage while facing Fibrodysplasia Ossificans Progressiva (FOP), a rare and challenging genetic condition. Her story highlights the power of early diagnosis, strong community support, and her family’s unwavering care. Diagnosis That Changed Her Life […]
Fibrodysplasia Ossificans Progressiva (FOP) remains one of the most misunderstood rare diseases. With only about 900 confirmed cases worldwide, public and even professional awareness is still alarmingly low. Misconceptions persist, leading to delays in diagnosis and sometimes irreversible harm. One common myth is that FOP is a form of arthritis or a post-injury complication. In […]
Treatment and research for Fibrodysplasia Ossificans Progressiva (FOP) are always changing, and 2025 will bring exciting new advancements and new hope. Even the slightest advancement in clinical trials and medication development can significantly improve the quality of life for individuals and their families afflicted by this extremely uncommon illness. The STOP-FOP trial’s entry into Phase […]
Introduction: What is IFOPA? The International Fibrodysplasia Ossificans Progressiva Association (IFOPA) is a global nonprofit dedicated to supporting individuals and families affected by Fibrodysplasia Ossificans Progressiva (FOP)—a rare and disabling genetic condition. Every week, IFOPA carries out vital work in areas such as support, research, education, and awareness. Here’s a roundup of what IFOPA did […]
In a powerful step toward building early recognition of rare diseases in India, FOP Trust India conducted a special awareness session with nursing faculty and students, equipping the next generation of healthcare professionals to identify and respond to Fibrodysplasia Ossificans Progressiva (FOP) with knowledge and sensitivity. 👩⚕️ Why Nurses Matter in Rare Disease Care Nurses […]
In the small village of Vishamangalam in Tamil Nadu, a 14-year-old boy named Bharath faces one of the world’s rarest diseases—Fibrodysplasia Ossificans Progressiva (FOP). But while his condition turns soft tissue into bone, what remains unbreakable is the spirit of a loving mother, a resilient child, and a hope for a better tomorrow. The First […]
